VINRKLB logo

Rekvina Labs Ltd

VINRKLB·BSE·
53.83 +1.05 (+1.99%)
Market Cap57.52 Cr
PE Ratio
Volume24,320
Day High - Low53.83 - 53.83
52W High-Low53.83 - 6.75
DocStoX Score
4.4/10
Weak
Fair Value
Sign in to see
ROE
41.27%
Strong
P/E
Debt / Equity
0.00
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

52W6.75
53.83
DocStoX take

Supported by growth (7.5) and momentum (7.5), but held back by valuation (0.0). Growth looks strong at 7.5, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
4.4
/10
Weak
Quality
Modest
ROE 41.3%
Valuation
Expensive
P/B 13.8× vs 3.4× warranted by ROE
Growth
Strong
Revenue +45.4% 10Y CAGR
Risk
Elevated
D/E 0.00
Momentum
Strong
100% of 52-week range

At a glance

Market Cap
₹58 Cr
52W High / Low
₹54 / ₹7
Dividend Yield
0.00%
Promoter Holding
77.00%
EPS (TTM)
₹-0.12
Book Value
₹3.47

Key highlights

  • Revenue compounding 45% a year
  • Capital works hard — ROCE 41%
  • Strong returns on equity (41%)
  • Loss-making in some of the last 5 years
  • Valuation is weak (0.0/10)
4 Positives3 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

Rekvina Labs Ltd peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.